Antiobesity effect of Gynostemma pentaphyllum extract (actiponin): a randomized, double-blind, placebo-controlled trial.

@article{Park2014AntiobesityEO,
  title={Antiobesity effect of Gynostemma pentaphyllum extract (actiponin): a randomized, double-blind, placebo-controlled trial.},
  author={Soo-hyun Park and Tae-lin Huh and Sun-Young Kim and Mi-Ra Oh and Pichiah Balasubramanian Tirupathi Pichiah and Soo-Wan Chae and Youn-Soo Cha},
  journal={Obesity},
  year={2014},
  volume={22 1},
  pages={
          63-71
        }
}
OBJECTIVE The effects of actiponin was investigated, a heat-processed Gynostemma pentaphyllum extract, on body weight, fat loss, and metabolic markers of Korean participants in a 12-week, randomized, double-blind, placebo-controlled clinical trial. DESIGN AND METHODS Obese participants (BMI ≥ 25 kg m(-2) and WHR ≥ 0.90 for male or WHR ≥ 0.85 for female) who had not been diagnosed with any disease and met the inclusion criteria were recruited for this study. The 80 subjects were randomly… CONTINUE READING
7
Twitter Mentions

Citations

Publications citing this paper.
SHOWING 1-7 OF 7 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 34 REFERENCES

Guidelines for Evaluation of the Efficacy of Functional Foods

KFDA Guideline
  • Korea Food and Drug Administration: Korea,
  • 2012
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Abbott to stop marketing the obesity medicine sibutramin in canada

E. Murphy
  • Abbott News 2010. [WWW document]
  • 2010
VIEW 1 EXCERPT